Viatris

Viatris is a global healthcare company formed in November 2020 through the merger of Mylan and Upjohn, a division of Pfizer. Headquartered in Canonsburg, Pennsylvania, it operates worldwide, including significant locations in Shanghai, China, and Hyderabad, India. The company is dedicated to expanding access to affordable, quality medicines and innovating to meet patient needs. Viatris develops, manufactures, markets, and distributes a diverse range of medicines, including brand-name products, generics, biosimilars, and over-the-counter offerings. Its therapeutic areas encompass infectious diseases, cardiovascular health, oncology, immunology, central nervous system disorders, and more. With around 50 manufacturing sites, Viatris produces various dosage forms and active pharmaceutical ingredients. The company also offers support services like diagnostic clinics and educational seminars to enhance healthcare delivery. Viatris serves a global customer base, including healthcare providers, pharmacies, and hospitals. It has a strong commercial presence across North America, Europe, Asia Pacific, and emerging markets, focusing on providing low-cost antiretroviral drugs for HIV treatment and other essential medicines.